Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

BUY
$209.01 - $232.56 $58,522 - $65,116
280 Added 0.45%
62,809 $13.7 Million
Q4 2023

Jan 30, 2024

BUY
$197.69 - $227.29 $15,024 - $17,274
76 Added 0.12%
62,529 $14.2 Million
Q3 2023

Oct 19, 2023

BUY
$201.05 - $221.7 $3,015 - $3,325
15 Added 0.02%
62,453 $12.6 Million
Q2 2023

Jul 20, 2023

BUY
$211.93 - $241.33 $102,786 - $117,045
485 Added 0.78%
62,438 $15.1 Million
Q1 2023

May 01, 2023

BUY
$213.32 - $257.83 $116,472 - $140,775
546 Added 0.89%
61,953 $14.2 Million
Q4 2022

Jan 20, 2023

BUY
$203.72 - $248.97 $10,593 - $12,946
52 Added 0.08%
61,407 $0
Q3 2022

Oct 18, 2022

BUY
$204.81 - $262.19 $873,309 - $1.12 Million
4,264 Added 7.47%
61,355 $12.6 Million
Q4 2021

Feb 14, 2022

BUY
$271.6 - $314.21 $15.5 Million - $17.9 Million
57,091 New
57,091 $17.9 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $19.4B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Mill Capital Management, LLC Portfolio

Follow Mill Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mill Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mill Capital Management, LLC with notifications on news.